Poxel S.A. (OTCMKTS:PXXLF) Short Interest Up 9,300.0% in February

Poxel S.A. (OTCMKTS:PXXLF) was the recipient of a significant increase in short interest in the month of February. As of February 15th, there was short interest totalling 9,400 shares, an increase of 9,300.0% from the January 31st total of 100 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Poxel Price Performance

OTCMKTS PXXLF opened at $0.25 on Friday. The business’s 50-day moving average is $0.25 and its 200 day moving average is $0.49. Poxel has a 1 year low of $0.25 and a 1 year high of $0.25.

About Poxel

Poxel SA, a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan.